These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Letter to the Editor in response to the article "Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?". Ceccarelli G; Nardi K; Marchesani F Pharmacol Res; 2020 Aug; 158():104933. PubMed ID: 32445955 [No Abstract] [Full Text] [Related]
4. Treatments for COVID-19: emerging drugs against the coronavirus - reply. Potì F Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921741 [No Abstract] [Full Text] [Related]
5. Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes. Authors' reply. Kosmaczewska A; Frydecka I Pol Arch Intern Med; 2020 Oct; 130(10):920-921. PubMed ID: 33119225 [No Abstract] [Full Text] [Related]
6. Pulmonary Fibrosis Due to COVID-19 Pneumonia. Kayhan S; Kocakoç E Korean J Radiol; 2020 Nov; 21(11):1273-1275. PubMed ID: 32729265 [No Abstract] [Full Text] [Related]
11. In Reply to the Letter to the Editor Regarding "Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community". Scullen T; Mathkour M; Keen JR World Neurosurg; 2020 Oct; 142():535-536. PubMed ID: 32585382 [No Abstract] [Full Text] [Related]
12. In Reply to 'Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?'. De Vriese AS; Reynders M Am J Kidney Dis; 2020 Oct; 76(4):598-599. PubMed ID: 32603712 [No Abstract] [Full Text] [Related]
13. Inhibiting IL-6 in COVID-19: we are not sure. Honore PM; Barreto Gutierrez L; Kugener L; Redant S; Attou R; Gallerani A; De Bels D Crit Care; 2020 Jul; 24(1):463. PubMed ID: 32718345 [No Abstract] [Full Text] [Related]
15. IL-6 may be a good biomarker for earlier detection of COVID-19 progression. Wang C; Fei D; Li X; Zhao M; Yu K Intensive Care Med; 2020 Jul; 46(7):1475-1476. PubMed ID: 32385523 [No Abstract] [Full Text] [Related]
18. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms. Raucci F; Mansour AA; Casillo GM; Saviano A; Caso F; Scarpa R; Mascolo N; Iqbal AJ; Maione F Autoimmun Rev; 2020 Jul; 19(7):102572. PubMed ID: 32376393 [No Abstract] [Full Text] [Related]
19. Hematologic parameters in patients with COVID-19 infection: a reply. Fan BE Am J Hematol; 2020 Aug; 95(8):E215. PubMed ID: 32339335 [No Abstract] [Full Text] [Related]
20. Perioperative Care for Patients with COVID-19: Reply. Liu Y; Chen X; Mi W Anesthesiology; 2020 Sep; 133(3):680-681. PubMed ID: 32675689 [No Abstract] [Full Text] [Related] [Next] [New Search]